Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 8
Submit an article Journal homepage
61
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Waldenström's Macroglobulinemia: A Review of Therapy

Morie A. Gertz Division of Hematology and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Pages 1517-1526 | Published online: 01 Jul 2009

  • Waldenström. J. (1990 "To treat or not to treat, this is the real question". Leuwkemia ResearcH 15, 407-408.
  • Gertz, M.A., Funseca. R. and Rajkumar. S.V. (2000) "Waldenström's macroglobalinemia". Oncologist 5, 63-67.
  • Kyle. R.A. and Garton. J.P. (1987) 'The spectrum of IgM monoclonal gammopathy in 430 cases (abstract)". Mayo Clinic Proceedings 62, 719 -731.
  • Facon. T., Brouillard. M., Duhamel. A., Morel. P., Simon. M., Jouet, J.P., Bauters. F. and Fenaux. P. (1993) "Prognostic factors in Waldenströtm's macroglobulinemia: a report of 167 cases". Journal of Clinical Oncology 11, 1553-1558.
  • Cass, R.M., Anderson. B.R. and Vaughan. J.H. (1969) "Waldenstrom's macroglobulinemia with increased serum IgG levels treated with low doses of cyctophosphamide", Annals of Internal Medicine 71, 971-977.
  • Oalakas, M.C, Flaum. M.A., Rick. M., Engel. W.K. and Gralnick. H.R. (1983) 'Treatment of polyneuropathy in Waldenström's macroglobulinemia: role of paraproteinemia and immunologie studies". Neumlogy 33, 1406-1410.
  • Kylec. R.A., Greipp". P.R. Gertz. M.A., Witzig, T.E., Lust. J.A., Lacy, M.Q. and Therneau. T.M. (2000) "Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil". British Journal of Haematology 108, 737-742.
  • Buckle. R.M., Jenkins. G.C. and Mills. G.L. (1966) "Waldenström's macroglobulinaemia treated with cyclophosphamide and chlorambucil". Journal of Clinical Pathology 19, 55-59.
  • Case. Jr., D.C. (1982) ''Combination chemotherapy (M-2) protocol (BCNU, cyclophosphamide, vincristine. melphalan, and prednisonel for Waldenström macroglobulinemia: preliminary report". Blood 59, 934-937.
  • Case. Jr., D.C., Ervin. T.J., Boyd, M.A. and Redfield, D.L. (1991) "Waldenström's macroglobulinemia: long-term results with the M2 protocol". Cancer Investigation 9, 1-7.
  • Petrucci. M.T., Avvisati. G., Tribalto. M., Giovangrossi. P. and Mandelli. F (1989) "Waldenström's macroglobulinaemia: results of a combined oral treatment in 34 newly diagnosed patient.s", Journal of Internal Medicine 226, 443-447.
  • Cardamone, J.M., Kimmerle, R.I. and Marshall. E.Y. (1974) "Development of acute erythroleukemia in B-cell immunoproliferative disorders after prolonged therapy with alkylating drugs". American Journal of Medicine 57, 836-842.
  • Petersen, H.S. (1973) "Erythroleukaemia in a melphalan-treated patient with primary macroglobulinaemia". Scandinavian Journal of Haematology 10, 5-11.
  • Horsman. D.E., Card. R.T. and Skinnider, L.F. (1953) "Waldenström macroglobulinemia terminating in acute leukemia: a report of three cases", American Journal of Hematotogy 15, 97-101.
  • Siddiqui. A., Mclamed, M.R., Abbi. R. and Ahmed. T. (1996) "Mucinous (colloid) carcinoma of urinary bladder following longterm cyclophosphamide therapy for Waldenström's macroglobulinemia". American Journal of Surgical Pathology 20, 500-504.
  • Rodriguez. J.N., Fernandez-Jurado. A., Martino. M.L. and Prados. D. (1998) "Waldenström's macroglobulinemia complicated with acute myeloid leukemia. Report of a case and review of the literature '. Haematologica 83, 91-92.
  • Kamarjian, H.M., Alexanian. R., Koller. C.A., Kurzrock. R. and Kealing, M.J. (1990) "Fludarabine therapy in macroglobulinemic lymphoma". Blood 75, 1928-1931.
  • Dimopoulos. M.A., O'Brien. S., Kantarjian, H., Pierce. S., Delasalle. K., Barlogie. B., Alexanian. R. and Keating. M.J. (1993) "Fludarabine therapy in Waldenström's macroglobulinemia". American Journal of Medicine 95, 49-52.
  • Zinzani. P.L., Gherlinzoni. F., Bendandi. M., Zaccaria. A., Aitini. E., Salvucci. M. and Tura. S. (1995) "Fludarabine treatment in resistant Waldenström'.s macroglobulinemia". European Journal of Haematology 54, 120-123.
  • Leblond. V, Ben-Othman. T., Deconinck. E., Taksin, A.I., Harousseau. J.L., Delgado. M.A., Delmer, A., Maloisel. F., Mariette. X., Morel. P., Clauvel. J.P., Duboisset, P., Entezam. S., Hermine, O., Merlet, M., Yakoub-Agha. I., Guibon, O., Caspard, H. and Fort, N. (1998) "Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Group Cooperatif Macroglohulinemie", Journal of Clinical Oncology 16, 2060-2064.
  • Thalhammer-Scherrer, R., Geissler, K., Schwarzinger. I., Chott, A., Gisslinger. H., Knobl, P., Lechner, K. and Jager. U. (2000) "Fludarabine therapy in Waldenström's macroglobulinemia". Annals of Hematology 79, 556-559.
  • Foran. J.M., Rohatiner. A.Z., Coiflier. B., Barbui, T., Johnson. S.A., Hiddemann. W., Radford. J.A., Norton. A.J., Tollerfield. S.M., Wilson. M.P. and Lister. T.A. (1999) "Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma. Waldenström's macroglobulinemia, and mantle-cell lymphoma". Journal of Clinical Oncology 17, 546-553.
  • Lévy, V, Porcher, R., Leblond, V, Hermand. J.P., Cazin, B., Maloiset. F., Harousseau. J.L., Remenieras. L., Guibon. O. and Chevret. S. (2000) "Evaluating treatment strategies in advanced Waldenström macroglobulinmia: use of quality adjusted survival analysis (abstract)". Blood 96(11), 760a.
  • Dhodapkar. M.V., Jacobson, J.L., Gertz. M.A., Rivkin. S.F., Roodman. G.D., Tuscano. J.M., Shurafa. M., Kyle. R.A., Crowley, J.J. and Barlogie. B. (2001) "Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003). Blood 98, 41-48.
  • Fenchel. K., Wijermans. P., Mitrou. P.S., Hoelzer. D. and Bergmann. U. (1994) "Fludarabine is an effective agent in immunocytic lymphoma". Onkologie 17, 508-513.
  • Bjorkholm. M., Celsing, F., Runarsson. G and Waldenström, J. (1995) "Successful intravenous immunoglobulin therapy for severe and persistent astrovirus gastroenteritis after fludarabine treatment in a patient with Waldenström's macroglobulinemia". International Journal of Hematology 62, 117-120.
  • Costa. P., Luzzati. R., Nicolato. A., Perboni. G., Scalzini. A., Lazzarini. L., Forghieri. M.E., Aitini, E. and Zinzani. P.L. (1998) "Cryptococcal meningitis and intracranial luberculoma in a patient with Waldenström's macroglobulinemia treated with fludarabine", Leukemia & Lymphoma 28, 617-620.
  • Dimopoulos. M.A., Kantarjian, H., Estey, E., O'Brien. S., Delasalle. K., Keating, M.J., Freireich, E.J. and Alexanian. R. (1993) 'Treatment of Waldenström macroglobulinemia with 2-chlorodeoxyadenosine". Annals of Internal Medicine 118, 195-198.
  • Delannoy, A., Ferrant. A., Martial, P., Bosley, A., Zenebergh, A. and Michaux. J.L. (1994) "2-Chlorodeoxyadenosine therapy in Waldenström's macroglobulinaemia". Nouvelle Revue Francaise J'Hematologie 36, 317-320
  • Liu. E.S., Burian. C. Miller. W.E. and Saven. A. (1998) "Bolus administration of Cladribine in the treatment of Waldenström macroglobulinaemia", British Journal of Haematology 103. 690-695.
  • Hellmann, A., Lewandowski. K., Zaucha. J.M., Bieniaszewska. M., Halaburda. K. and Robak. T. (1999) "Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia". European Journal of Haemotology 63, 35-41.
  • Fridrik. M.A., Jager. G., Baldinger. C., Krieger. O., Chott. A. and Bettelheim. P (1997) "First-line treatment of Waldenström's disease with cladribine. Arbeitsgemeinschaft Medikamentose Tumortherapie". Annals of Hematology 74, 7-10.
  • Beiticher. D.C., Hsu Schmitz. S.F., Ratschiller. D., von Rohr. A., Egger. T., Pugin. P., Stalder. M., Hess, U., Fey. M.F. and Cerny. T. (1997) "Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia. Swiss Group for Clinical Cancer Research (SAKK)", British Journal of Haematology 99, 358-363.
  • Dunopoulos, M.A., Weber. D.M., Kantaijian. H., Keating. M. and Alexanian, R. (1994) "2-Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine". Annals of Oncology 5, 288-289.
  • Baltz. J.K. and Momello. M.J. (1993) "Cladribine for the treatment of hematologie malignancies". Clinical Pharmacy 12, 805-813.
  • Bryson. H.M. and Sorkin. F.,M. (1993) "Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies". Drugs 46. 872-894.
  • Van Den Neste. E., Louviaux. L., Michaux. J.L., Delannoy. A., Michaux. L., Sonet. A., Bosly. A., Doyen. C., Mineur, P., Andre. M., Straetmans. N., Coche. E., Venet. C., Duprez, T. and Ferrant. A. (1999) "Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2'-deoxyadenosine". British Journal of Haematology 105, 268-270.
  • Tetrcault. S.A. and Saven. A. (2000) "Delayed onset of onset autoimmune hemolytic anemia complicating cladribine therapy for Waldenström macroglobulinemia", Leukemia & Lymphoma 37, 125-130.
  • Weide. R., Heymanns. J. and Koppler, H. (1999) "Induction of complete haematological remission after monotherapy with antiCD20 monoclonal antibody (RITUXlMAB) in a patient with alkylaling agent resistant Waldenström's macroglobulinaemia". Leukemia A Lymphoma 36, 203-206.
  • Weide. R., Heymanns. J. and Koppler. H. (2000) "The polyneuropathy associated with Waldenström's macroglobulinaemia can be treated effectively with chemotherapy and the anti-CD20 monoclonal antibody rituximab". British Journal of Haemutology 109, 838-841.
  • Treon. S.P., Shima. Y., Preffer. EL., Doss. D.S., Ellman, I., Schlossman, R.L., Grossbard, M.I.,. Belch. A.R., Pilarski. L.M. and Anderson. K.C. (1999) "Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy". Seminars in Oncology Suppl. 14, 97-106.
  • Byrd. J.C., White. C.A., Link. B., Luca.s. M.S., Velasquez. W.S., Rosenberg. J. and Grillo-Lopez. A.J. (1999) "Rituximab therapy in Waidenström's macroglobulinemia: preliminary evidence of clinical activity". Annals of Oncology 10, 1525-1527.
  • White. C.A. (1999) "Rituximab immunotherapy for non-Hodgkin's lymphoma". Cancer Biotherapy & Radiopharmaceuticals 14, 241-250.
  • Treon. S.P. and Anderson. K.C. (2000) "The use of rituximab in the treatment of malignant and nonmalignant plasma cell disorders". Seminars in Oncology Suppl. 12, 79-85.
  • Treon. S.P., Agus. D.B., Link. B., Rodrigues, G., Molina. A., Lacy. M.Q., Fisher. D.C., Emmanouilides. C., Richards, A.I., Clark. B., Lucas. M.S., Schlossman. R., Schenkein, D., Lin, B., Kimby. E., Anderson. K.C. and Byrd. J.C. (2001) "CD20-Directed antibodymediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenström's macroglobulinemia". Journal of Immunotherapy 24, 272-279.
  • Diniopoulos. M.A., Kiamouris. C., Karkantaris. C.,Mitsouli. C. and Viniou. N. (2000) "Prospective evaluation of rituximab for the treatment of Waldenström's macroglobulinemia (abstract)". Blood 96(11). 169a.
  • Treon. S.P. Milsiades. CS., Mitsiades, N.S., Young. G., Doss. D.S., Schlossman. R.L., and Anderson. K.C. (2000) 'Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in B-cell malignancies (abstract)". Blood 96(11). 99a.
  • Gomez, G.A., »an. T., Ozer. Fl. and Henderson. E.S. (1984) 'Treatment of refractory lymphoproliferative diseases with daily, low-dose vincristine. continuous infusion of bleomycin and highdose prednisone". Medical and Pediatric Oncology 12, 239-243.
  • O'Reilly. R.A. and MacKenzie. M.R. (1967) "Primary macrocryogelglobulinemia. Remission with adrenal cortieosteroid therapy". Archives of Internal Medicine 120, 234-238.
  • Jane. S.M. and Salem. H.H. (1988) "Treatment of resistant Waldenström's macroglobulinemia with high dose glucocorticosteroids". Australian and New Zealand Journal of Medicine 18, 77-78.
  • Dimopoulos. M.A., Viniou. N., Zomas. A., Grigoraki. V., Galani. E., Matsouka. C., Economou, O., Anagnoslopoulos. N. and Panayiotides. P. (2000) "Treatment of Waldenström's macroglobulinemia with thalidomide (abstract)". Blood 96(11). 286b.
  • Coleman. M., Leonard. J.P. and Nahum. K. (2000) "Nonmyelosuppressive therapy with BLT-D (Biaxin. low dose thalidomide and dexamethasone) is highly active in Waldenstrom's macroglobulinemia and myeloma (abstract)",Blood 96(11). 167a.
  • Schlesinger. N., Neustadter. L. and Schumacher. H.R. (2000) "Lytic bone lesions as a prominent feature in Waldenström's macroglobulinemia", Journal of Clinical Rheumatology 6, 150-153.
  • Shehata. W.M. (1977) "Report of a case of Waldenström macroglobulinemia treated and controlled by radiotherapy". Blood 49, 1023-1024.
  • Richards. J.D., Coates. P.B., Closs. S.P., Tobias. J.S. and Joannides. T. (1983) "Case of macroglobulinaemia treated with hemibody irradiation". Lancet 2, 844.
  • Richaud. P., Hoerni-Simon, G, Denepoux, R., Durand, M., Hoerni. B. and Lagarde. C. (1979) "Total body irradiation (T.B.I.). Preliminary results of a new technique in 30 patients with hematologic malignancy", Strahlentherapie 155, 736-739.
  • Desikan. R., Dhodapkar. M., Siegel. D., Passas. A., Singh. J., Singhal, S., Mehta, J., Vesole, D., Tricot. G., Jagannath, S., Anaissie. E., Barlogie. B. and Munshi. N.C. (1999) "High-dose therapy with autologous haemopoietic stem cell support for Waldenström's macroglobulinaemia". British Journal of Haematology 105, 993-996.
  • Dreger. P., Glass. B., Kuse. R., Sonnen. R., von Neuhoff. N., Bolouri. H., Kneba, M. and Schmitz. N. (1999) "Myeloablative radiochemotherapy followed by rein fusion of purged autologous stem cells for Waldenström's macroglobulinaemia", British Journal of Haematology 106, 115-118.
  • Yang. L., Wen. B., Li. H., Yang. M., Jin. Y. Yang, S. and Tao. J (1999) "Autologous peripheral blood stem cell transplantation for Waldenström's macroglobulinemia". Bone Marrow Transplantation 24, 929-930.
  • Martina. R., Shah. A., Romero. P., Brunei. S., Sierra, J., DomingoAlbos. A., Fruchtman. S. and Isola. L. (1999) "AIIogeneic bone marrow transplantation for advanced Waldenström's maoroglobulinemia". Bone Marrow Transplantation 23, 747-749.
  • Anagnostopoulos. A., Dimopoulos, M.A., Aleman. A., Weber. D., Alexanian. R., Champlin, R. and Giralt. S. (2001) "High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenström's macroglobulinemia (abstract)". Bone Marrow Transplantation 27, 1027-1029.
  • Laurencet. P.M., Zulian. G.B., Guctty-Alberto. M., lien. P.A., Betticher. D.C. and Alberto, P. (1999) "Cladribine with cyctophosphamide and prednisone in the management of low-grade lymphoproliterative malignancies". British Journal of Cancer 79. 1215-1219.
  • Van Den Neste, F.,. Louviaux. I., Michaux. J.L., Delannoy. A., Michaux. I.,. Sonet. A., Bosly. A., Doyen. C. Mineur. P., Andre. M., Straetmans, N., Coche, K., Venet, C, Duprex. T. and Ferrant. A. (2000) "Phase I/II study of 2-chIoro-2'-deoxyadenosine with cyclophosphaimide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma". Leukemia 14, 1136-1142.
  • Weber. D.M., Delasalle. K., Gavino. M., Wood. A., Cabanillas. F. and Alexanian. R. (1997) "Primary treatment of Waldenström's macroglobulinemia (WM) with subcutaneous 2-chlorodeoxyadenosine (2-CdA) and oral cyclophosphamide (abstract)", Blood 90(Suppl. 1), 357a.
  • Brody, J.I.,Haidar. M.E. and Rossman. R.E. (1979) "A hemorrhagic syndrome in Waldenström's macroglobulinemia secondary to immunoadsorption of factor VIlI. Recovery after splenectomy". New England Journal Medicine 300, 408-410.
  • Nagai. M., Ikeda, K., Nakamura. H., Ohnishi. H, Amino, Y., Irino, S., Sato. A. and Uda. H. (1991) "Splenectomy for a case with Waldenström macroglobulinemia with giant splenomegaly". American Journal of Hematology 37, 140.
  • Humphrey. J.S. and Conley, CL. (1995) 'Durable complete remission of macroglobulinemia after splenectomy: a report of two cases and review of the literature". American Journal of Hematology 48, 262-266.
  • Takemori, N., Hirai. K., Onodera, R., Kimura. S. and Katagiri. M. (1997) "Durable remission after splenectomy for Waldenström's macroglobulinemia with massive splenomegaly in leukemic phase". foukemia a Lymphoma 26, 387-393.
  • Winter. A.J., Obeid. D. and Jones. E.I., (1995) "Long survival after splenic immunoblastic transformation of Waldenström's macroglobulinaemia". British Journal of Haematology 91, 412-414.
  • Ohno, R., Kodera, Y., Ogura. M., Murase. T., Emi, N., Okumura. M., Morishita. Y., Nagura. E., Minami. S., Morishima. Y. Kawashima, K., Yokomaku. S. Kobayashi. M. and Takeyama. H. (1985) "Treatment of plasma cell neoplasm with recombinant leukocyte A interferon and human lymphoblastoid interferon". Cancer Chemotherapy and Pharmacology 14, 34-37.
  • Bhavnani. M., Marples. J. and Yin. J.A. (1990) "Treatment of Waldenström's macroglobulinemia with alpha interferon". Journal of Clinical Pathology 43, 437.
  • De Rosa. G., De Reruo. A., Buffardi, S. and Rotoli, B. (1989) "Treutment of Waldenström's macroglobulinemia with interferon". Haematologica 74, 313-315.
  • Legouffe. E., Rossi. J.F., Lapone. J.R. Isnard, R, Oziol. E., Fabbro. M., Janbon, C. Jourdan. J. and Najman. A. (1995) "Treatment of Waldenström's macroglobulinemia with very low doses of alpha interferon". Leukemia & Lymphoma 19, 337-342.
  • Rotoli, B., Dc Renzo. A., Frigeri, F, Buffardi. S., Marceno, R., Cavallaro. A.M., Ruggeri P., Liso. V., Musto. P., Andriani. A., Callea. V., Pizzuti, M., Iannitto. E., Cimino, R., Molica. S., Citarrella, P., Musolino. C, Guarino. S., LucareIIi. G., Espinosa. A. and Del Vecchio. L. (1994) "A phase II trial on alpha-interferon (alpha [FN) effect in patients with monoclonal IgM gammopathy". Leukemia & Lymphoma 13, 463-469.
  • Thomas. E.L., Oik. R.J., Markman. M., Braine. H. and Patz. A. (1983) "Irreversible visual loss in Waldenström's macroglobulinaemia". The British Journal of Ophthalmology 67, 102-106.
  • Clark. W.F., Rock. G.A., Buskard. N., Shumak, K.H., LeBlood. P., Anderson. D. and Sutton, D.M. (1999) "Therapeutic plasma exchange: an update from the Canadian Apheresis Group", Annals of Internal Medicine 131, 453-462.
  • Buskard. N.A., Gallon. D.A., Goldinan. J.M., Kohner. E.M., Grindle. C.F. Newman. D.L., Twinn, K.W. and Loenthal, R.M. (1977) "'Plasma exchange in the long-term management of Wuldenström's macroglobulinemia". Canadian Medical Association Journal 117, 135-137.
  • Avnstorp. C., Nielsen. H., Drachmann. O. and Hippe. E. (1985) "Plasmapheresis in hyperviscosity syndrome", Acta Medica Scandinavica. 217, 133 -137.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.